Switzerland-based Carbogen Amcis, a pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, has opened a state-of-the-art facility in Saint-Beauzire, France.
Source: Supplied.
The new site is dedicated to the custom development and production of sterile injectable drug products.
Built on newly acquired land located 7km from an existing Carbogen Amcis site in Riom, the new facility increases product development and manufacturing capacity for liquid and freeze-dried products for pre-clinical and clinical trials as well as small-scale commercial use.
Carbogen Amcis has more than 15 years’ experience of developing safe injectable and liquid pharmaceutical forms for a wide range of disease areas.
Construction started on the new site in January 2021. The facility forms two new fully-automated production lines for liquid and freeze-dried drug…
